Drugging the undruggable: gabapentin, pregabalin and the calcium channel α₂δ subunit

References

• Alden KJ, Garcia J. (2001). Differential effect of gabapentin on neuronal and muscle calcium currents. J Pharmacol Exp Ther 297:727–35.
   PubMed Web of Science ®Google Scholar
• Arikkath J, Campbell KP. (2003). Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol 13:298–307.
   PubMed Web of Science ®Google Scholar
• Barton ME, Eberle EL, Shannon HE. (2005). The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil. Eur J Pharmacol 521:79–85.
   PubMed Web of Science ®Google Scholar
• Bauer CS, Tran-Van-Minh A, Kadurin I, Dolphin AC. (2010). A new look at calcium channel α2δ subunits. Curr Opin Neurobiol 20:563–71.
   PubMed Web of Science ®Google Scholar
• Belliotti TR, Capiris T, Ekhato IV, et al. (2005). Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein. J Med Chem 48:2294–307.
   PubMed Web of Science ®Google Scholar
• Bertrand S, Ng GY, Purisai MG, et al. (2001). The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels. J Pharmacol Exp Ther 298:15–24.
   PubMed Web of Science ®Google Scholar
• Bertrand S, Nouel D, Morin F, et al. (2003). Gabapentin actions on Kir3 currents and N-type Ca2+ channels via GABAB receptors in hippocampal pyramidal cells. Synapse 50:95–109.
   PubMed Web of Science ®Google Scholar
• Bockbrader HN, Wesche D, Miller R, et al. (2010). A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 49:661–9.
   PubMed Web of Science ®Google Scholar
• Brown JP, Gee NS. (1998). Cloning and deletion mutagenesis of the alpha2 delta calcium channel subunit from porcine cerebral cortex. Expression of a soluble form of the protein that retains [3H]gabapentin binding activity. J Biol Chem 273:25458–65.
   PubMed Web of Science ®Google Scholar
• Canti C, Davies A, Dolphin AC. (2003). Calcium channel α2δ subunits: structure, functions and target site for drugs. Curr Neuropharmacol 1:209–17.
   Google Scholar
• Catterall WA. (2011). Voltage-gated calcium channels. Cold Spring Harb Perspect Biol 3:a003947.
   PubMed Web of Science ®Google Scholar
• Chaires JB. (2008). Calorimetry and thermodynamics in drug design. Annu Rev Biophys 37:135–51.
   PubMed Web of Science ®Google Scholar
• Dalby NO, Nielsen EB. (1997). Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res 28:63–72.
   PubMed Web of Science ®Google Scholar
• Dolphin AC. (2009). Calcium channel diversity: multiple roles of calcium channel subunits. Curr Opin Neurobiol 19:237–44.
   PubMed Web of Science ®Google Scholar
• Dolphin AC. (2012). Calcium channel auxiliary α2δ and β subunits: trafficking and one step beyond. Nat Rev Neurosci 13:542–55.
   Google Scholar
• Eroglu C, Allen NJ, Susman MW, et al. (2009). Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 139:380–92.
   PubMed Web of Science ®Google Scholar
• Errante LD, Petroff O. (2003). Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure 12:300–6.
   PubMed Web of Science ®Google Scholar
• Errante LD, Williamson A, Spencer DD, Petroff OAC. (2002). Gabapentin and vigabatrin increase GABA in the human neocortical slice. Epilepsy Res 49:203–10.
   PubMed Web of Science ®Google Scholar
• Field MJ, McCleary S, Hughes J, Singh L. (1999). Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 80:391–8.
   PubMed Web of Science ®Google Scholar
• Field MJ, Cox PJ, Stott E, et al. (2006). Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 103:17537–42.
   PubMed Web of Science ®Google Scholar
• Fink K, Dooley DJ, Meder WP, et al. (2002). Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 42:229–36.
   PubMed Web of Science ®Google Scholar
• Froestl W. (2011). An historical perspective on GABAergic drugs. Future Med Chem 3:163–75.
   PubMed Web of Science ®Google Scholar
• Gale K. (1989). GABA in epilepsy: the pharmacologic basis. Epilepsia 30 Suppl s3:s1–11.
   Web of Science ®Google Scholar
• Gee NS, Brown JP, Dissanayake VU, et al. (1996). The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 271:5768–76.
   PubMed Web of Science ®Google Scholar
• Goldlust A, Su T-Z, Welty DF, et al. (1995). Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Res 22:1–11.
   PubMed Web of Science ®Google Scholar
• Griffith M, Griffith OL, Coffman AC, et al. (2013). DGIdb: mining the druggable genome. Nat Methods 10:1209–10.
   PubMed Web of Science ®Google Scholar
• Hendrich J, Van Minh AT, Heblich F, et al. (2008). Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin. Proc Natl Acad Sci USA 105:3628–33.
   PubMed Web of Science ®Google Scholar
• Hill DR, Suman-Chauhan N, Woodruff GN. (1993). Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies. Eur J Pharmacol 244:303–9.
   PubMed Web of Science ®Google Scholar
• Honmou O, Kocsis JD, Richerson GB. (1995). Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in vitro. Epilepsy Res 20:193–202.
   PubMed Web of Science ®Google Scholar
• Hopkins AL, Groom CR. (2002). The druggable genome. Nat Rev Drug Discov 1:727–30.
   PubMed Web of Science ®Google Scholar
• Hoppa MB, Lana B, Margas W, et al. (2012). α2δ expression sets presynaptic calcium channel abundance and release probability. Nature 486:122–5.
   PubMed Web of Science ®Google Scholar
• Hoppa MB, Gouzer G, Armbruster M, Ryan TA. (2014). Control and plasticity of the presynaptic action potential waveform at small CNS nerve terminals. Neuron 84:778–89.
   PubMed Web of Science ®Google Scholar
• Janssen SF, van der Spek SJF, Brink ten JB, et al. (2013). Gene expression and functional annotation of the human and mouse choroid plexus epithelium. PLoS One 8:e83345.
   PubMed Web of Science ®Google Scholar
• Jensen AA, Mosbacher J, Elg S, et al. (2002). The anticonvulsant gabapentin (neurontin) does not act through gamma-aminobutyric acid-B receptors. Mol Pharmacol 61:1377–84.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S. (2000). KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27–30.
   PubMed Web of Science ®Google Scholar
• Kim C. (2001). Altered nociceptive response in mice deficient in the α1B subunit of the voltage-dependent calcium channel. Mol Cell Neurosci 18:235–45.
   PubMed Web of Science ®Google Scholar
• Klugbauer N, Marais E, Hofmann F. (2003). Calcium channel alpha2delta subunits: differential expression, function, and drug binding. J Bioenergetics Biomembr 35:639–47.
   PubMed Web of Science ®Google Scholar
• Kocsis JD, Honmou O. (1994). Gabapentin increases GABA-induced depolarization in rat neonatal optic nerve. Neurosci Lett 169:181–4.
   PubMed Web of Science ®Google Scholar
• Krall RL, Penry JK, Kupferberg HJ, Swinyard EA. (1978). Antiepileptic drug development: I. History and a program for progress. Epilepsia 19:393–408.
   PubMed Web of Science ®Google Scholar
• Lanneau C, Green A, Hirst WD, et al. (2001). Gabapentin is not a GABAB receptor agonist. Neuropharmacology 41:965–75.
   PubMed Web of Science ®Google Scholar
• Leach JP, Sills GJ, Butler E, et al. (1997). Neurochemical actions of gabapentin in mouse brain. Epilepsy Res 27:175–80.
   PubMed Web of Science ®Google Scholar
• Li Z, Taylor CP, Weber M, et al. (2011). Pregabalin is a potent and selective ligand for α2δ-1 and α2δ-2 calcium channel subunits. Eur J Pharmacol 667:80–90.
   PubMed Web of Science ®Google Scholar
• Lotarski SM, Donevan S, El-Kattan A, et al. (2011). Anxiolytic-like activity of pregabalin in the Vogel conflict test in α2δ-1 (R217A) and α2δ-2 (R279A) mouse mutants. J Pharmacol Exp Ther 338:615–21.
   PubMed Web of Science ®Google Scholar
• Lotarski S, Hain H, Peterson J, et al. (2014). Anticonvulsant activity of pregabalin in the maximal electroshock-induced seizure assay in α2δ1 (R217A) and α2δ2 (R279A) mouse mutants. Epilepsy Res 108:833–42.
   PubMed Web of Science ®Google Scholar
• Löscher W, Hönack D, Taylor CP. (1991). Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci Lett 128:150–4.
   PubMed Web of Science ®Google Scholar
• Löscher W, Rogawski MA. (2012). How theories evolved concerning the mechanism of action of barbiturates. Epilepsia 53:12–25.
   PubMed Web of Science ®Google Scholar
• Luan C-H, Light SH, Dunne SF, Anderson WF. 2014. Ligand screening using fluorescence thermal shift analysis (FTS). In: Williams M, Daviter T, eds. Protein-ligand interactions. Methods in molecular biology. New York, NY: Springer, 263–289.
   Google Scholar
• Macdonald RL. (1989). Antiepileptic drug actions. Epilepsia 30 Suppl:S19–S28. discussion S64–8.
   Web of Science ®Google Scholar
• Macdonald RL, Kelly KM. (1995). Antiepileptic drug mechanisms of action. Epilepsia 36 Suppl:S2–S12.
   Web of Science ®Google Scholar
• Magano J, Bowles D, Conway B, et al. (2009). Diastereoselective, large-scale synthesis of β-amino acids via asymmetric aza-Michael addition as α2δ ligands for the treatment of generalized anxiety disorder and insomnia. Tetrahedron Lett 50:6325–28.
   Web of Science ®Google Scholar
• Martin DJ, McClelland D, Herd MB, et al. (2002). Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression. Neuropharmacology 42:353–66.
   PubMed Web of Science ®Google Scholar
• McLean MJ. (1995). Gabapentin. Epilepsia 36 Suppl:S73–S86.
   Web of Science ®Google Scholar
• Merritt HH, Putnam TJ. (1938). A new series of anticonvulsant drugs tested by experiments on animals. Arch Neurol Psychiatry 39:1003–15.
   Google Scholar
• Mewes HW. (2004). MIPS: analysis and annotation of proteins from whole genomes. Nucleic Acids Res 32:41D–4D.
   PubMed Web of Science ®Google Scholar
• Morgan PT, Pace-Schott EF, Mason GF, et al. (2012). Cortical GABA levels in primary insomnia. Sleep 35:807–14.
   PubMed Web of Science ®Google Scholar
• Morrow J. (2006). Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatr 77:193–8.
   PubMed Web of Science ®Google Scholar
• Mølgaard-Nielsen D, Hviid A. (2011). Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA 305:1996–2002.
   PubMed Web of Science ®Google Scholar
• Neely GG, Hess A, Costigan M, et al. (2010). A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene. Cell 143:628–38.
   PubMed Web of Science ®Google Scholar
• Ng GY, Bertrand S, Sullivan R, et al. (2001). Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol Pharmacol 59:144–52.
   PubMed Web of Science ®Google Scholar
• Pedruzzi I, Rivoire C, Auchincloss AH, et al. (2012). HAMAP in 2013, new developments in the protein family classification and annotation system. Nucleic Acids Res 41:D584–9.
   PubMed Web of Science ®Google Scholar
• Petroff OA, Rothman DL, Behar KL, et al. (1996). The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. AnnNeurol 39:95–9.
   Web of Science ®Google Scholar
• Polc P, Mohler H, Haefely W. (1974). The effect of diazepam on spinal cord activities: possible sites and mechanisms of action. Naunyn-Schmiedeberg's Arch Pharmacol 284:319–37.
   Google Scholar
• Petroff OA, Rothman DL, Behar KL, et al. 2012. Mechanisms of action of antiseizure drugs. Handb Clin Neurol 108:663–81.
   PubMedGoogle Scholar
• Radulovic LL, Türck D, Hodenberg von A, et al. (1995). Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys. Drug Metab Dispos 23:441–8.
   PubMed Web of Science ®Google Scholar
• Rock DM, Kelly KM, Macdonald RL. (2002). Gabapentin actions on ligand-and voltage-gated responses in cultured rodent neurons. Epilepsy Res 16:89–98.
   Web of Science ®Google Scholar
• Rogawski MA, Löscher W. (2004). The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10:685–92.
   PubMed Web of Science ®Google Scholar
• Saegusa H, Kurihara T, Zong S, et al. (2000). Altered pain responses in mice lacking alpha 1E subunit of the voltage-dependent Ca2+ channel. Proc Natl Acad Sci USA 97:6132–7.
   PubMed Web of Science ®Google Scholar
• Saegusa H, Matsuda Y, Tanabe T. (2002). Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. Neurosci Res 43:1–7.
   PubMed Web of Science ®Google Scholar
• Saegusa H, Kurihara T, Zong S, et al. (2003). Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psych 160:577–9.
   PubMed Web of Science ®Google Scholar
• Satzinger G. (1974). Antiepileptics from gamma-aminobutyric acid. Arzneimittel-Forschung 44:261–6.
   Google Scholar
• Scannell JW, Blanckley A, Boldon H, Warrington B. (2012). Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov 11:191–200.
   PubMed Web of Science ®Google Scholar
• Schechter PJ. (1989). Clinical pharmacology of vigabatrin. Br J Clin Pharmacol 27 Suppl:19S–22S.
   Web of Science ®Google Scholar
• Schumacher TB, Beck H, Steinhäuser C, et al. (1998). Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy. Epilepsia 39:355–63.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Honda M, Tanabe M, Ono H. (2004). GABAB receptors do not mediate the inhibitory actions of gabapentin on the spinal reflex in rats. J Pharmacol Sci 96:444–9.
   PubMed Web of Science ®Google Scholar
• Silverman RB. (2008). From basic science to blockbuster drug: the discovery of Lyrica. Angew Chem Int Ed 47:3500–4.
   PubMed Web of Science ®Google Scholar
• Silverman RB, Andruszkiewicz R. (1991). 3-Alkyl-4-aminobutyric acids: the first class of anticonvulsant agents that activates L-glutamic acid decarboxylase. J Med Chem 34:2295–8.
   PubMed Web of Science ®Google Scholar
• Stahl SM, Porreca F, Taylor CP, et al. (2013). The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities? Trends Pharmacol Sci 34:332–9.
   PubMed Web of Science ®Google Scholar
• Stefani A, Spadoni F, Bernardi G. (1998). Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology 37:83–91.
   PubMed Web of Science ®Google Scholar
• Sternbach LH. (1979). The benzodiazepine story. J Med Chem 22:1–7.
   PubMed Web of Science ®Google Scholar
• Streeter CC, Whitfield TH, Owen L, et al. (2010). Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study. J Alternat Complement Med 16:1145–52.
   PubMed Web of Science ®Google Scholar
• Suman-Chauhan N, Webdale L, Hill DR, Woodruff GN. (1993). Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur J Pharmacol 244:293–301.
   PubMed Web of Science ®Google Scholar
• Suzdak PD, Jansen JA. (1995). A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia 36:612–26.
   PubMed Web of Science ®Google Scholar
• Sweatt AJ, Garcia-Espinosa MA, Wallin R, Hutson SM. (2004). Branched-chain amino acids and neurotransmitter metabolism: expression of cytosolic branched-chain aminotransferase (BCATc) in the cerebellum and hippocampus. J Comparat Neurol 477:360–70.
   PubMed Web of Science ®Google Scholar
• Takada M, Kang Y, Imanishi M. (2001). Immunohistochemical localization of voltage-gated calcium channels in substantia nigra dopamine neurons. Eur J Neurosci 13:757–62.
   PubMed Web of Science ®Google Scholar
• Taylor CP, Vartanian MG, Po-Wai Y, et al. (2002). Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res 14:11–5.
   Web of Science ®Google Scholar
• Thorpe AJ, Offord J. (2010). The alpha2-delta protein: an auxiliary subunit of voltage-dependent calcium channels as a recognized drug target. Curr Opin Investig Drugs (London, England: 2000) 11:761–70.
   PubMedGoogle Scholar
• Timmerman W, Bouma M, De Vries JB, et al. (2000). A microdialysis study on the mechanism of action of gabapentin. Eur J Pharmacol 398:53–7.
   PubMed Web of Science ®Google Scholar
• Tran-Van-Minh A, Dolphin AC. (2010). The alpha2/delta ligand gabapentin inhibits the Rab11-dependent recycling of the calcium channel subunit alpha2/delta-2. J Neurosci 30:12856–67.
   PubMed Web of Science ®Google Scholar
• van Hooft JA, Dougherty JJ, Endeman D, et al. (2002). Gabapentin inhibits presynaptic Ca(2+) influx and synaptic transmission in rat hippocampus and neocortex. Eur J Pharmacol 449:221–8.
   PubMed Web of Science ®Google Scholar
• Vartanian MG, Radulovic LL, Kinsora JJ, et al. (2006). Activity profile of pregabalin in rodent models of epilepsy and ataxia. Epilepsy Res 68:189–205.
   PubMed Web of Science ®Google Scholar
• Venter JC, Adams MD, Myers EW, et al. (2001). The sequence of the human genome. Science 291:1304–51.
   PubMed Web of Science ®Google Scholar
• Wafford KA, Ebert B. (2008). Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time. Nat Rev Drug Discov 7:530–40.
   PubMed Web of Science ®Google Scholar
• Wang M, Offord J, Oxender DL, Su T-Z. (1999). Structural requirement of the calcium-channel subunit alpha2delta for gabapentin binding. Biochem J 342:313–20.
   PubMed Web of Science ®Google Scholar
• Wermeling DP. (2005). Ziconotide, an intrathecally administered N‐type calcium channel antagonist for the treatment of chronic pain. Pharmacotherapy: J Hum Pharmacol Drug Ther 25:1084–94.
   Web of Science ®Google Scholar
• Yamamoto H, Shimoshige Y, Yamaji T, et al. (2009). Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats. Neuropharmacology 57:403–8.
   PubMed Web of Science ®Google Scholar
• Yokoyama CT, Westenbroek RE, Hell JW, et al. (1995). Biochemical properties and subcellular distribution of the neuronal class E calcium channel alpha 1 subunit. J Neurosci 15:6419–32.
   PubMed Web of Science ®Google Scholar